Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives

Dwan-Ying Chang,1 Wei-Li Ma,1,2 Yen-Shen Lu1 1Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 2Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence: Yen-Shen LuDepartment of Oncology, National Taiwan University Hosp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chang DY, Ma WL, Lu YS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/f9bbf567c77d45949e2cc7fdf4e7b24a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares